Yassaman Vafai, Edwina H Yeung, Rajeshwari Sundaram, Melissa M Smarr, Nicole Gerlanc, William A Grobman, Daniel Skupski, Edward K Chien, Stefanie N Hinkle, Roger B Newman, Deborah A Wing, Angela C Ranzini, Anthony Sciscione, Jagteshwar Grewal, Cuilin Zhang, Katherine L Grantz
BACKGROUND: The association between obesity (body mass index (BMI) ≥ 30 kg/m2 ) and pattern of medication use during pregnancy in the United States is not well-studied. Higher pre-pregnancy BMI may be associated with increases or decreases in medication use across pregnancy as symptoms (e.g. reflux) or comorbidities (e.g. gestational diabetes) requiring treatment that may be associated with higher BMI could also change with advancing gestation. OBJECTIVES: To determine whether prenatal medication use, by the number and types of medications, varies by pre-pregnancy obesity status...
March 11, 2021: Journal of Maternal-fetal & Neonatal Medicine